Ascendis Pharma A/S - Common Stock (ASND)

CUSIP: 04351P101

Q3 2024 13F Holders as of 30 Sep 2024

Holder snapshot 7 signals
Share change
+1,337,019
Put/Call ratio
151%
SEC-reported price per share
$149.31
Number of holders
218
Value change
+$237,478,312
Number of buys
117
Open additional details 1 more signal available
Number of sells
93
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
62,915,156

Security key

04351P101

Report period

Q3 2024

Institutions

218

Top holders

10

Ownership snapshot

Top reported holders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
0/15
Latest evidence
30 Jun 2024
13F Highest disclosed value: $1,378,583,592 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. has the largest disclosed position value at $1.38B.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.
Disclosed position value Top 5
RA CAPITAL MANAGEMENT, L.P. $1.38B
WESTFIELD CAPITAL MANAGEMENT CO LP $676.83M
FMR LLC $671.34M
Artisan Partners Limited Partnership $585.76M
Avoro Capital Advisors LLC $572.34M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13F
—
denominator unverified
$1,378,583,592
10,108,400 shares
— 30 Jun 2024
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
13F
—
denominator unverified
$676,829,960
4,962,824 shares
— 30 Jun 2024
FMR LLC
13F
Company
13F
—
denominator unverified
$671,338,051
4,922,555 shares
— 30 Jun 2024
Artisan Partners Limited Partnership
13F
Company
13F
—
denominator unverified
$585,756,055
4,295,029 shares
— 30 Jun 2024
Avoro Capital Advisors LLC
13F
Company
13F
—
denominator unverified
$572,340,627
4,196,661 shares
— 30 Jun 2024
Janus Henderson Group Ltd.
13F
Company
13F
—
denominator unverified
$534,488,464
3,918,813 shares
— 30 Jun 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
218
Shares
62,595,716
Rows available
218
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
202
Q3 2024 holders
218
Holder diff
16
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 value Q3 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .